By Haryana gets response on global tender from Malta-based pharma company for Sputnik V vaccines
An international pharmaceutical company headquartered in Malta, Pharma Regulatory Services Limited, has expressed interest in providing Haryana with up to 60 million doses of the Sputnik V vaccine, manufactured by the Gamaleya Institute and marketed by the Russian Direct Investment Fund (RDIF), said the state government.
“An international pharma company with headquarters in Malta namely Pharma Regulatory Services Limited has given an expression of interest to provide up to 60mn does of Sputnik V vaccine manufactured by the Gamaleya Institute and the Russian Direct Investment Fund,” the state government said in a press note.
Latest News and updates, Follow and connect with us on Google News, Facebook, Twitter, and Linkedin
Get the latest updates directly on your mobile, save and send a message at +91-9899909957 on Whatsapp to start
